Perioperative Management of Adderall (Amphetamine/Dextroamphetamine)
Adderall does not need to be discontinued before elective surgery and can be safely continued through the perioperative period.
Evidence-Based Recommendation
The available evidence strongly supports continuing amphetamine therapy perioperatively rather than discontinuing it 1. A case series of 8 patients taking chronic prescription amphetamines (prescribed for 2-10 years) who underwent general anesthesia demonstrated safe intraoperative courses with no significant cardiovascular instability 1. These patients underwent procedures ranging from 30 minutes to 4.25 hours, with 6 of 8 requiring tracheal intubation, and all had stable outcomes 1.
Rationale for Continuation
Cardiovascular Safety Profile
- Historical concerns about catecholamine depletion and blunted response to hypotension have not materialized in clinical practice 1
- The theoretical risk of intraoperative hypotension due to chronic amphetamine use causing catecholamine depletion was not observed in actual surgical patients 1
- No significant increase in hypotension or arrhythmias occurred in patients continuing their amphetamine therapy 1
Risks of Discontinuation
- Discontinuing chronic medications before surgery generally carries more risk than benefit, particularly for agents where withdrawal syndromes exist 2
- Abrupt cessation of amphetamines can lead to rebound ADHD symptoms, fatigue, depression, and cognitive impairment that may complicate postoperative recovery 3
- The principle of continuing chronic psychiatric medications perioperatively is well-established, as demonstrated with antidepressants where discontinuation increased delirium and confusion (30% vs 13%) without reducing anesthetic complications 4
Anesthetic Considerations
Intraoperative Management
- Anesthesiologists should be informed that the patient is taking amphetamines to allow appropriate monitoring and medication selection 1
- Direct-acting vasopressors (phenylephrine, epinephrine) should be used preferentially over indirect-acting agents if hemodynamic support is needed 2
- Standard anesthetic techniques are appropriate; no special "amphetamine-safe" protocols are required 1
Monitoring Requirements
- Routine cardiovascular monitoring is sufficient 1
- No additional specialized monitoring is required beyond standard ASA guidelines 1
Comparison with Similar Medications
This recommendation differs significantly from phentermine, another sympathomimetic medication used for weight loss, which requires discontinuation at least 4 days before procedures requiring anesthesia due to risks of hyperadrenergic effects and paradoxical refractory hypotension 5. The key distinction is that therapeutic amphetamines for ADHD at prescribed doses have a different risk profile than appetite suppressants like phentermine 5, 1.
Common Pitfalls to Avoid
- Do not confuse prescription amphetamines for ADHD with illicit amphetamine abuse - the perioperative management differs significantly 1
- Do not automatically discontinue all sympathomimetic medications - each class has distinct perioperative considerations 5, 1
- Avoid indirect-acting vasopressors (ephedrine) if possible, as amphetamines may alter their effectiveness 2
Practical Implementation
- Continue the patient's usual morning dose of Adderall on the day of surgery 1
- Document amphetamine use clearly in the anesthetic record 1
- Ensure adequate postoperative pain control, as amphetamines do not interfere with opioid analgesia 1
- Resume normal dosing schedule immediately postoperatively once oral intake is tolerated 1